Absence of QTc prolongation in a thorough QT study with imeglimin, a first in class oral agent for type 2 diabetes mellitus von Dubourg, Julie, Perrimond-Dauchy, Sandrine, Felices, Mathieu, Bolze, Sébastien, Voiriot, Pascal, Fouqueray, Pascale

Volltext

Observations of a large Dent disease cohort von Blanchard, Anne, Curis, Emmanuel, Guyon-Roger, Tiphaine, Kahila, Diana, Treard, Cyrielle, Baudouin, Véronique, Bérard, Etienne, Champion, Gérard, Cochat, Pierre, Dubourg, Julie, de la Faille, Renaud, Devuyst, Olivier, Deschenes, Georges, Fischbach, Michel, Harambat, Jérôme, Houillier, Pascal, Karras, Alexandre, Knebelmann, Bertrand, Lavocat, Marie-Pierre, Loirat, Chantal, Merieau, Elodie, Niaudet, Patrick, Nobili, François, Novo, Robert, Salomon, Rémi, Ulinski, Tim, Jeunemaître, Xavier, Vargas-Poussou, Rosa

Volltext

Lack of Drug–Drug Interaction Between Cimetidine, a Renal Transporter Inhibitor, and Imeglimin, a Novel Oral Antidiabetic Drug, in Healthy Volunteers von Chevalier, Clémence, Perrimond-Dauchy, Sandrine, Dubourg, Julie, Fouqueray, Pascale, Bolze, Sébastien

Volltext

Percutaneous biopsy of lesions in the cavernous sinus region through the foramen ovale: diagnostic accuracy and limits in 50 patients von Messerer, Mahmoud, Dubourg, Julie, Saint-Pierre, Ghislaine, Jouanneau, Emmanuel, Sindou, Marc

Volltext

Challenges and opportunities in NASH drug development von Harrison, Stephen A., Allen, Alina M., Dubourg, Julie, Noureddin, Mazen, Alkhouri, Naim

Volltext

Signification of distal urinary acidification defects in hypocitraturic patients von Forni Ogna, Valentina, Blanchard, Anne, Vargas-Poussou, Rosa, Ogna, Adam, Baron, Stéphanie, Bertocchio, Jean-Philippe, Prot-Bertoye, Caroline, Nevoux, Jérôme, Dubourg, Julie, Maruani, Gérard, Mendes, Margarida, Garcia-Castaño, Alejandro, Treard, Cyrielle, Lepottier, Nelly, Houillier, Pascal, Courbebaisse, Marie

Volltext

Clinical Trial Landscape in NASH von Harrison, Stephen A., Loomba, Rohit, Dubourg, Julie, Ratziu, Vlad, Noureddin, Mazen

Volltext

Efficacy and Safety of Imeglimin Monotherapy Versus Placebo in Japanese Patients With Type 2 Diabetes (TIMES 1): A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Mul... von Dubourg, Julie, Fouqueray, Pascale, Thang, Carole, Grouin, Jean-Marie, Ueki, Kohjiro

Volltext

Liver biopsy evaluation in MASH drug development: Think thrice, act wise von Harrison, Stephen A., Dubourg, Julie

Volltext

Ultrasonography of optic nerve sheath diameter for detection of raised intracranial pressure: a systematic review and meta-analysis von Dubourg, Julie, Javouhey, Etienne, Geeraerts, Thomas, Messerer, Mahmoud, Kassai, Behrouz

Volltext

Editorial: Liver hypercortisolism as a potential target for MASH treatment von Harrison, Stephen A, Dubourg, Julie

Volltext

Non-functioning pituitary macro-incidentalomas benefit from early surgery before becoming symptomatic von Messerer, Mahmoud, Dubourg, Julie, Raverot, Gérald, Bervini, David, Berhouma, Moncef, George, Ipe, Chacko, Ari George, Perrin, Gilles, Levivier, Marc, Daniel, Roy Thomas, Trouillas, Jacqueline, Jouanneau, Emmanuel

Volltext

FGF21 agonists: An emerging therapeutic for metabolic dysfunction-associated steatohepatitis and beyond von Harrison, Stephen A., Rolph, Tim, Knott, Madeline, Dubourg, Julie

Volltext

Long‐term safety and efficacy of imeglimin as monotherapy or in combination with existing antidiabetic agents in Japanese patients with type 2 diabetes (TIMES 2): A 52‐week, open‐l... von Dubourg, Julie, Fouqueray, Pascale, Quinslot, Damien, Grouin, Jean‐Marie, Kaku, Kohei

Volltext

Sports-related chronic repetitive head trauma as a cause of pituitary dysfunction von Dubourg, Julie, Messerer, Mahmoud

Volltext

Hyperinsulinemia, an overlooked clue and potential way forward in metabolic dysfunction-associated steatotic liver disease von Harrison, Stephen A, Dubourg, Julie, Knott, Maddie, Colca, Jerry

Volltext

FRI-247 Association of plasma magnesium with MASH and cirrhosis: combined data from multiple therapeutic trials including more than 10, 000 patients von Harrison, Stephen A., Dubourg, Julie, Ratziu, Vlad, Schattenberg, Jörn M., Alkhouri, Naim, Noureddin, Mazen, Charlton, Michael

Volltext

WED-213 Assessment of fibrosis change rates in placebo arm of metabolic dysfunction-associated steatohepatitis drug trials based on pathologist readouts and qFibrosis continuous va... von Akbary, Kutbuddin, Tai, Dean, Gan, Galvin, Dubourg, Julie, Harrison, Stephen A.

Volltext

SAT-450 Exploring racial, ethnic, and demographics representativeness in MASH clinical trials: combined data from multiple therapeutic trials including more than 10, 000 patients von Schattenberg, Jörn M., Alkhouri, Naim, Noureddin, Mazen, Ratziu, Vlad, Charlton, Michael, Dubourg, Julie, Harrison, Stephen A.

Volltext

FRI-199 Insulin resistance as an independent predictor of metabolic dysfunction-associated steatohepatitis (MASH) severity: combined data from multiple therapeutic trials including... von Ratziu, Vlad, Schattenberg, Jörn M., Alkhouri, Naim, Noureddin, Mazen, Charlton, Michael, Dubourg, Julie, Harrison, Stephen A.

Volltext